Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Nov 5 - Nov 10
The phase 2 clinical trial was conducted in the U.S
However, the pricing landscape has shifted significantly in 2026 due to manufacturer discount programs, competitive pressure, and government negotiations
But a Hunterbrook Media investigation reveals that the compounder Hims has partnered with to manufacture these drugs BPI Labs LLC is wholly owned by Belcher Pharmaceuticals LLC, a business with a history of FDA scrutiny and former executives convicted of fraud
Reduced SCFA production means less GLP-1 stimulation from L-cells
US$ 28.03
US$ 21.34
US$ 28.70
